Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “erythropoietin”

5 pharma patents match "erythropoietin" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "erythropoietin" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “erythropoietin” · 30,257 patents in full index Clear search

  1. US 11197812

    Cosmetic formulations for topical applications containing erythropoietin-derived molecules

    ASC REGENITY LIMITED · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  2. US 10912791

    Compositions comprising antisense-encoded erythropoietin receptor and use thereof

    The Board of Regents of the University of Texas System · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted

  3. US 10456346

    Cosmetic formulations for topical applications containing erythropoietin-derived molecules

    ASC REGENITY LIMITED · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted

  4. US 10233452

    Compositions and methods for increasing erythropoietin (EPO) production

    Alnylam Pharmaceuticals, Inc. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  5. US 7300915

    Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain

    The Regents of the University of California · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.